Site saturation (or lack thereof) is a big driver for global clinical research
Written by Andres Heuberger on Wednesday, July 15, 2009
We have already mentioned Kendle's article Latin American Clinical Trial Authorizations (PDF link) back in June but it just keeps on giving.
Another interesting piece of data in the article is based on FDA Form 1572 data. It shows how clinical trial sites are heavily concentrated in the western world:
| Region | Number of trial sites/1,000,000 inhabitants |
| U.S. | 82 |
| Western Europe | 11 |
| Central/Eastern Europe | 8 |
| Latin America | 2 |
| Asia-Pacific | <1 |
It is no surprise then that clinical research is going global and expanding outside the traditional areas. With significantly fewer sites competing for patient populations, CROs and sponsors find that recruitment is easier, allowing emerging market sites to produce more patients per site per month than sites in traditional regions.
For international clinical trial and clinical translation news, subscribe to the Medical Translation Insight via email or RSS!
0 Comments:
Subscribe to:
Post Comments (Atom)
